Investment
Features
FeesSafety
Academy
More
Pluang+

Compare New York Times Co (NYT) vs 22nd Century Group Inc (XXII) Price & Performance

New York Times CoTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

New York Times Co vs 22nd Century Group Inc — how do they compare? New York Times Co trades at $66.32 (market cap $10.74B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: New York Times Co is far larger — about 17276× 22nd Century Group Inc's market cap, and New York Times Co pays a 1.38% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold New York Times Co for 81 Days and 22nd Century Group Inc for 32 Days on average.

NYTXXII
Market Cap
$10.74B$621.67K
Volume
2,096,35245,625
Sector
MediaConsumer Staples
52-Week High
$85.86$483.00
52-Week Low
$54.66$0.80
Typical Hold Time
81 Days32 Days
Enterprise Value
$10.14B-$3.69M
Dividend Yield
1.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

New York Times Co

The New York Times Company (NYT) trades at $66.60, up 2.62% today, reflecting strong momentum after three consecutive quarterly earnings beats. Revenue and net income have grown steadily from 2022 to 2025, with profit margins expanding to 12.17%. The stock shows a bullish technical signal overall, supported by positive cash flow trends and a declared quarterly dividend of $0.23 per share. However, a recent shareholder lawsuit alleging reporting bias introduces reputational risk.

Outlook remains positive given consistent earnings outperformance and a consensus price target of $84.00, implying significant upside. Key risks include the ongoing lawsuit, competitive pressures in digital media, and potential volatility from the AI copyright dispute with OpenAI. The company's solid fundamentals and analyst support suggest resilience, but investors should weigh legal and market challenges.

22nd Century Group Inc

XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.

While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NYT
13% Buy87% Sell
Avg holding period · 81 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

About New York Times Co

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.

Read more on NYT →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →